1. Home
  2. BGMS vs SNOA Comparison

BGMS vs SNOA Comparison

Compare BGMS & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BGMS

Bio Green Med Solution Inc.

HOLD

Current Price

$1.53

Market Cap

5.8M

Sector

N/A

ML Signal

HOLD

Logo Sonoma Pharmaceuticals Inc.

SNOA

Sonoma Pharmaceuticals Inc.

BUY

Current Price

$1.17

Market Cap

6.1M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
BGMS
SNOA
Founded
1996
1999
Country
Malaysia
United States
Employees
19
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8M
6.1M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
BGMS
SNOA
Price
$1.53
$1.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.4K
125.1K
Earning Date
05-08-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,288,000.00
Revenue This Year
N/A
$23.00
Revenue Next Year
$80,482.35
$24.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.19
52 Week Low
$0.73
$0.85
52 Week High
$6.70
$6.92

Technical Indicators

Market Signals
Indicator
BGMS
SNOA
Relative Strength Index (RSI) 85.39 41.48
Support Level $0.85 $1.00
Resistance Level $5.15 $1.23
Average True Range (ATR) 0.16 0.08
MACD 0.06 0.05
Stochastic Oscillator 50.53 51.72

Price Performance

Historical Comparison
BGMS
SNOA

About BGMS Bio Green Med Solution Inc.

Bio Green Med Solution Inc is engaged in the supply and trading of protective and fire safety equipment. The company distributes products such as fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and safety apparel. It also provides fire safety systems, including sprinkler systems, fire alarm systems, valves, and CO2 systems. The company operates across commercial, industrial, healthcare, and residential sectors, with a focus on distribution and compliance with applicable safety standards.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: